Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

Market Cap	64.75B -9.9%
Revenue (ttm)	306.77B +3.0%
Net Income	6.17B +40.2%
EPS	1.67 +41.6%
Shares Out	n/a
PE Ratio	10.49
Forward PE	11.36
Dividend	0.45 (3.98%)
Ex-Dividend Date	Dec 29, 2025

Volume	1,139,280
Average Volume	1,819,913
Open	11.29
Previous Close	11.29
Day's Range	11.25 - 11.48
52-Week Range	10.06 - 13.12
Beta	0.34
RSI	40.47
Earnings Date	Mar 31, 2026

About HKG:2607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,402
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2607

Financial Performance

In 2024, HKG:2607's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY